HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $567,610 | -13.8% | 17,321 | -7.5% | 0.00% | -33.3% |
| Q2 2023 | $658,757 | -4.5% | 18,720 | -11.4% | 0.00% | 0.0% |
| Q1 2023 | $689,568 | +54196.7% | 21,120 | -8.3% | 0.00% | -50.0% |
| Q4 2022 | $1,270 | +17.7% | 23,044 | -5.4% | 0.01% | +20.0% |
| Q3 2022 | $1,079 | -99.9% | 24,354 | +12.4% | 0.01% | 0.0% |
| Q2 2022 | $1,057,000 | -4.6% | 21,672 | -4.8% | 0.01% | +25.0% |
| Q1 2022 | $1,108,000 | +52.6% | 22,767 | +33.7% | 0.00% | +33.3% |
| Q4 2021 | $726,000 | – | 17,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |